Cancer-Killing Molecule: Scientists Mimic Nature’s Design
- This article details a groundbreaking revelation by researchers at Imperial College london and the University of Cologne: bacteria living within tumors can produce a molecule, 2-methylisocitrate (2-MiCit), that...
- * Tumor-Associated Microbiome: Scientists are increasingly recognizing that tumors aren't just composed of cancer cells, but also harbor their own bacterial communities.
- In essence, the research suggests that harnessing the chemical interactions between bacteria and cancer cells could be a promising new avenue for improving cancer treatment outcomes.
Summary of the Article: Bacteria Enhance Chemotherapy Effectiveness
This article details a groundbreaking revelation by researchers at Imperial College london and the University of Cologne: bacteria living within tumors can produce a molecule, 2-methylisocitrate (2-MiCit), that boosts the effectiveness of chemotherapy, specifically 5-fluorouracil (5-FU), in treating colorectal cancer.
Here are the key takeaways:
* Tumor-Associated Microbiome: Scientists are increasingly recognizing that tumors aren’t just composed of cancer cells, but also harbor their own bacterial communities.
* Discovery of 2-MiCit: Researchers identified 2-MiCit, produced by E. coli, as a compound that considerably increases the potency of the chemotherapy drug 5-FU.
* Broad Validation: The discovery was validated through multiple experiments:
* Testing in microscopic worms (C. elegans)
* Computer modeling of patient tumor microbiomes
* Experiments with cultured human cancer cells
* A fly model of colorectal cancer (where it also extended lifespan)
* Mechanism of Action: 2-MiCit disrupts cancer cell metabolism by inhibiting a key enzyme in the mitochondria, making them more vulnerable to chemotherapy.
* Potential for New Therapies: This finding opens doors for developing new therapies that leverage the power of the tumor microbiome to enhance existing cancer treatments.
In essence, the research suggests that harnessing the chemical interactions between bacteria and cancer cells could be a promising new avenue for improving cancer treatment outcomes.